A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
Vous n'êtes pas connecté
In a new mouse-model study presented at bENDO 2025/b, the researchers observed that tirzepatide, a drug that is approved to treat type 2 diabetes
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
A new study has found that a drug used for treating obesity and type 2 diabetes may also help slow the growth of breast cancer caused by obesity. The...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth...
Tirzepatide reduces breast tumor growth in obese mice while improving metabolic health, offering hope as a dual-action cancer and weight-loss...
A new study has found that an anti-obesity drug called tirzepatide, which is sold under the names Mounjaro for diabetes and Zepbound for obesity, may...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro...
A major new study led by researchers in Leicester has revealed that women with type 2 diabetes face almost double the risk of undetected heart...
A new study has found that linoleic acid, a common fat found in seed oils like soybean and safflower oil, can increase the growth of a dangerous type...
A new study has found that linoleic acid, a common fat found in seed oils like soybean and safflower oil, can increase the growth of a dangerous type...
A new preclinical study from Weill Cornell Medicine reveals that linoleic acid, a type of omega-6 fatty acid commonly found in seed oils and animal...